Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat

The entry of the coronavirus SARS-CoV-2 into human lung cells can be inhibited by the approved drugs camostat and nafamostat. Here we elucidate the molecular mechanism of these drugs by combining experiments and simulations. In vitro assays confirm that both drugs inhibit the human protein TMPRSS2,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hempel, Tim, Raich, Lluís, Olsson, Simon, Azouz, Nurit P., Klingler, Andrea M., Hoffmann, Markus, Pöhlmann, Stefan, Rothenberg, Marc E., Noé, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906443/
https://www.ncbi.nlm.nih.gov/pubmed/35382133
http://dx.doi.org/10.1039/d0sc05064d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906443/
https://www.ncbi.nlm.nih.gov/pubmed/35382133
http://dx.doi.org/10.1039/d0sc05064d

Ejemplares similares